Covered recipient · General Payments record
DOUGLAS D BAILEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$3,719.63
- Reported across 247 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.24 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $36.52 | 2 |
| Acerta Pharma LLC | $29.56 | 2 |
| PFIZER INC. | $16.48 | 1 |
| Avanir Pharmaceuticals, Inc. | $15.84 | 1 |
| Janssen Pharmaceuticals, Inc | $14.72 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.68 | 1 |
| Novo Nordisk AS | $14.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $22.01 | 01/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793960671 | CMS |
| AbbVie Inc. | $14.51 | 01/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793960677 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.33 | 01/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 830030035 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.23 | 01/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 829723459 | CMS |
| Avanir Pharmaceuticals, Inc. | $15.84 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801026189 | CMS |
| Janssen Pharmaceuticals, Inc | $14.72 | 01/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788880967 | CMS |
| Novo Nordisk Inc | $14.44 | 02/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836094033 | CMS |
| PFIZER INC. | $16.48 | 02/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833450439 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.68 | 02/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819857409 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.